Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 130

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 130
---
 restrictions under each Lease.                                                           |

E-16

| 40. | Title and Sufficiency of Company Assets |

| (a) | Each of the Company or the Subsidiary has good and marketable title to the Company Assets free and clear of any 
 Encumbrances (other than Permitted Encumbrances), in all material respects.                                     |

| (b) | The Company is not aware of any defects, failures or impairments in the title of the Company Assets, whether or                                                                                      
 not an action, suit, proceeding or inquiry is pending or threatened or whether or not discovered by any third party, which in aggregate, could reasonably be expected to be material to the Company. |

| 41. | Bank Accounts and Powers of Attorney |

Schedule 41 of the Disclosure Letter is a complete and accurate list showing (i) the name of each bank in which the Company or the Subsidiary has an account or safety deposit box and the names of all persons authorized to draw on the account or to have access to the safety deposit box; and (ii) the names of all persons holding powers of attorney from the Company or the Subsidiary. Copies of the powers of attorney, if any, have been made available to the Purchaser.

| 42. | Fairness Opinion |

The Transaction Committee has received the Fairness Opinion. The Fairness Opinion has not been withdrawn or modified. The Company has been authorized by the Financial Advisor to include the Fairness Opinion in the Circular.

| 43. | Board and Transaction Committee Approval |

| (a) | The Transaction Committee, after consultation with its financial and legal advisors, has unanimously                                                                                                                                             
 recommended that the consideration to be received under the Arrangement is fair from a financial point of view to the Shareholders and that it would be in the best interests of the Company and the Shareholders for the Company to support and 
 facilitate the Arrangement, enter into this Agreement and to take all reasonable action to support the Arrangement and to recommend acceptance of the Arrangement to the Shareholders.                                                           |

| (b) | After consultation by the Board of Directors with its financial and legal advisors and the Transaction 
 Committee, the members of the Board of Directors who voted thereon have unanimously determined that:   |

| (i) | the Contemplated Transactions are in the best interests of the Company and the Shareholders and, accordingly,                                                                                                       
 has unanimously approved the entering into of this Agreement and the making of the Board Recommendation and no